Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron
Hemolysis (i.e., red blood cell lysis) can increase circulatory levels of cell-free hemoglobin (Hb) and its degradation by-products, namely heme (h) and iron (Fe). Under homeostasis, minor increases in these three hemolytic by-products (Hb h Fe) are rapidly scavenged and cleared by natural plasma pr...
Gespeichert in:
| Veröffentlicht in: | Annual review of biomedical engineering 2023-06, Vol.25 (1), p.1-21 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 21 |
|---|---|
| container_issue | 1 |
| container_start_page | 1 |
| container_title | Annual review of biomedical engineering |
| container_volume | 25 |
| creator | Pires, Ivan S Berthiaume, François Palmer, Andre F |
| description | Hemolysis (i.e., red blood cell lysis) can increase circulatory levels of cell-free hemoglobin (Hb) and its degradation by-products, namely heme (h) and iron (Fe). Under homeostasis, minor increases in these three hemolytic by-products (Hb h Fe) are rapidly scavenged and cleared by natural plasma proteins. Under certain pathophysiological conditions, scavenging systems become overwhelmed, leading to the accumulation of Hb h Fe in the circulation. Unfortunately, these species cause various side effects such as vasoconstriction, hypertension, and oxidative organ damage. Therefore, various therapeutics strategies are in development, ranging from supplementation with depleted plasma scavenger proteins to engineered biomimetic protein constructs capable of scavenging multiple hemolytic species. In this review, we briefly describe hemolysis and the characteristics of the major plasma-derived protein scavengers of Hb h Fe. Finally, we present novel engineering approaches designed to address the toxicity of these hemolytic by-products. |
| doi_str_mv | 10.1146/annurev-bioeng-081622-031203 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_37289555</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2824687324</sourcerecordid><originalsourceid>FETCH-LOGICAL-a435t-41a5144613d768a012640ac59f813d091dc88e2308b9475be933af0c349a5f983</originalsourceid><addsrcrecordid>eNqVkE9Lw0AQxRdRrFa_guTgwUOj-zfZBUFKrbZQ8FLPyyad1JV0t-4mar-9KanePc1jeO_N8EPomuBbQnh2Z5xrA3ymhfXg1imWJKM0xYxQzI7QGRFcpJzm_HivKUuVpGqAzmN8xxgrxvgpGrCcSiWEOEMPU7e2DiBYt06WbxDMFtrGljFpfPIIjf-21S6Zwcava19YN9prGCXGrZJ58O4CnVSmjnB5mEP0-jRdTmbp4uV5PhkvUsOZaFJOjCCcZ4St8kwaTGjGsSmFqmS3woqsSimBMiwLxXNRQPeoqXDJuDKiUpIN0U3fuw3-o4XY6I2NJdS1ceDbqKmkPJM5o7yz3vfWMvgYA1R6G-zGhJ0mWO8R6gNC3SPUPULdI-ziV4dLbbGB1V_4l1lnGPeGfY2puyILX_F_R34AX5WGCg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2824687324</pqid></control><display><type>article</type><title>Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron</title><source>Annual Reviews Complete A-Z List</source><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Pires, Ivan S ; Berthiaume, François ; Palmer, Andre F</creator><creatorcontrib>Pires, Ivan S ; Berthiaume, François ; Palmer, Andre F</creatorcontrib><description>Hemolysis (i.e., red blood cell lysis) can increase circulatory levels of cell-free hemoglobin (Hb) and its degradation by-products, namely heme (h) and iron (Fe). Under homeostasis, minor increases in these three hemolytic by-products (Hb h Fe) are rapidly scavenged and cleared by natural plasma proteins. Under certain pathophysiological conditions, scavenging systems become overwhelmed, leading to the accumulation of Hb h Fe in the circulation. Unfortunately, these species cause various side effects such as vasoconstriction, hypertension, and oxidative organ damage. Therefore, various therapeutics strategies are in development, ranging from supplementation with depleted plasma scavenger proteins to engineered biomimetic protein constructs capable of scavenging multiple hemolytic species. In this review, we briefly describe hemolysis and the characteristics of the major plasma-derived protein scavengers of Hb h Fe. Finally, we present novel engineering approaches designed to address the toxicity of these hemolytic by-products.</description><identifier>ISSN: 1523-9829</identifier><identifier>EISSN: 1545-4274</identifier><identifier>DOI: 10.1146/annurev-bioeng-081622-031203</identifier><identifier>PMID: 37289555</identifier><language>eng</language><publisher>United States: Annual Reviews</publisher><subject>haptoglobin ; Haptoglobins - metabolism ; Haptoglobins - therapeutic use ; heme ; Heme - metabolism ; hemoglobin ; Hemoglobins - metabolism ; hemolysis ; Hemolysis - physiology ; hemopexin ; Humans ; Iron</subject><ispartof>Annual review of biomedical engineering, 2023-06, Vol.25 (1), p.1-21</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a435t-41a5144613d768a012640ac59f813d091dc88e2308b9475be933af0c349a5f983</citedby><cites>FETCH-LOGICAL-a435t-41a5144613d768a012640ac59f813d091dc88e2308b9475be933af0c349a5f983</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.annualreviews.org/content/journals/10.1146/annurev-bioeng-081622-031203?crawler=true&mimetype=application/pdf$$EPDF$$P50$$Gannualreviews$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.annualreviews.org/content/journals/10.1146/annurev-bioeng-081622-031203$$EHTML$$P50$$Gannualreviews$$Hfree_for_read</linktohtml><link.rule.ids>70,314,776,780,4168,27901,27902,77996,77997</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37289555$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pires, Ivan S</creatorcontrib><creatorcontrib>Berthiaume, François</creatorcontrib><creatorcontrib>Palmer, Andre F</creatorcontrib><title>Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron</title><title>Annual review of biomedical engineering</title><addtitle>Annu Rev Biomed Eng</addtitle><description>Hemolysis (i.e., red blood cell lysis) can increase circulatory levels of cell-free hemoglobin (Hb) and its degradation by-products, namely heme (h) and iron (Fe). Under homeostasis, minor increases in these three hemolytic by-products (Hb h Fe) are rapidly scavenged and cleared by natural plasma proteins. Under certain pathophysiological conditions, scavenging systems become overwhelmed, leading to the accumulation of Hb h Fe in the circulation. Unfortunately, these species cause various side effects such as vasoconstriction, hypertension, and oxidative organ damage. Therefore, various therapeutics strategies are in development, ranging from supplementation with depleted plasma scavenger proteins to engineered biomimetic protein constructs capable of scavenging multiple hemolytic species. In this review, we briefly describe hemolysis and the characteristics of the major plasma-derived protein scavengers of Hb h Fe. Finally, we present novel engineering approaches designed to address the toxicity of these hemolytic by-products.</description><subject>haptoglobin</subject><subject>Haptoglobins - metabolism</subject><subject>Haptoglobins - therapeutic use</subject><subject>heme</subject><subject>Heme - metabolism</subject><subject>hemoglobin</subject><subject>Hemoglobins - metabolism</subject><subject>hemolysis</subject><subject>Hemolysis - physiology</subject><subject>hemopexin</subject><subject>Humans</subject><subject>Iron</subject><issn>1523-9829</issn><issn>1545-4274</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkE9Lw0AQxRdRrFa_guTgwUOj-zfZBUFKrbZQ8FLPyyad1JV0t-4mar-9KanePc1jeO_N8EPomuBbQnh2Z5xrA3ymhfXg1imWJKM0xYxQzI7QGRFcpJzm_HivKUuVpGqAzmN8xxgrxvgpGrCcSiWEOEMPU7e2DiBYt06WbxDMFtrGljFpfPIIjf-21S6Zwcava19YN9prGCXGrZJ58O4CnVSmjnB5mEP0-jRdTmbp4uV5PhkvUsOZaFJOjCCcZ4St8kwaTGjGsSmFqmS3woqsSimBMiwLxXNRQPeoqXDJuDKiUpIN0U3fuw3-o4XY6I2NJdS1ceDbqKmkPJM5o7yz3vfWMvgYA1R6G-zGhJ0mWO8R6gNC3SPUPULdI-ziV4dLbbGB1V_4l1lnGPeGfY2puyILX_F_R34AX5WGCg</recordid><startdate>20230608</startdate><enddate>20230608</enddate><creator>Pires, Ivan S</creator><creator>Berthiaume, François</creator><creator>Palmer, Andre F</creator><general>Annual Reviews</general><scope>ZYWBE</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20230608</creationdate><title>Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron</title><author>Pires, Ivan S ; Berthiaume, François ; Palmer, Andre F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a435t-41a5144613d768a012640ac59f813d091dc88e2308b9475be933af0c349a5f983</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>haptoglobin</topic><topic>Haptoglobins - metabolism</topic><topic>Haptoglobins - therapeutic use</topic><topic>heme</topic><topic>Heme - metabolism</topic><topic>hemoglobin</topic><topic>Hemoglobins - metabolism</topic><topic>hemolysis</topic><topic>Hemolysis - physiology</topic><topic>hemopexin</topic><topic>Humans</topic><topic>Iron</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pires, Ivan S</creatorcontrib><creatorcontrib>Berthiaume, François</creatorcontrib><creatorcontrib>Palmer, Andre F</creatorcontrib><collection>Annual Reviews Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annual review of biomedical engineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pires, Ivan S</au><au>Berthiaume, François</au><au>Palmer, Andre F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron</atitle><jtitle>Annual review of biomedical engineering</jtitle><addtitle>Annu Rev Biomed Eng</addtitle><date>2023-06-08</date><risdate>2023</risdate><volume>25</volume><issue>1</issue><spage>1</spage><epage>21</epage><pages>1-21</pages><issn>1523-9829</issn><eissn>1545-4274</eissn><abstract>Hemolysis (i.e., red blood cell lysis) can increase circulatory levels of cell-free hemoglobin (Hb) and its degradation by-products, namely heme (h) and iron (Fe). Under homeostasis, minor increases in these three hemolytic by-products (Hb h Fe) are rapidly scavenged and cleared by natural plasma proteins. Under certain pathophysiological conditions, scavenging systems become overwhelmed, leading to the accumulation of Hb h Fe in the circulation. Unfortunately, these species cause various side effects such as vasoconstriction, hypertension, and oxidative organ damage. Therefore, various therapeutics strategies are in development, ranging from supplementation with depleted plasma scavenger proteins to engineered biomimetic protein constructs capable of scavenging multiple hemolytic species. In this review, we briefly describe hemolysis and the characteristics of the major plasma-derived protein scavengers of Hb h Fe. Finally, we present novel engineering approaches designed to address the toxicity of these hemolytic by-products.</abstract><cop>United States</cop><pub>Annual Reviews</pub><pmid>37289555</pmid><doi>10.1146/annurev-bioeng-081622-031203</doi><tpages>21</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1523-9829 |
| ispartof | Annual review of biomedical engineering, 2023-06, Vol.25 (1), p.1-21 |
| issn | 1523-9829 1545-4274 |
| language | eng |
| recordid | cdi_pubmed_primary_37289555 |
| source | Annual Reviews Complete A-Z List; MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | haptoglobin Haptoglobins - metabolism Haptoglobins - therapeutic use heme Heme - metabolism hemoglobin Hemoglobins - metabolism hemolysis Hemolysis - physiology hemopexin Humans Iron |
| title | Engineering Therapeutics to Detoxify Hemoglobin, Heme, and Iron |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T08%3A32%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engineering%20Therapeutics%20to%20Detoxify%20Hemoglobin,%20Heme,%20and%20Iron&rft.jtitle=Annual%20review%20of%20biomedical%20engineering&rft.au=Pires,%20Ivan%20S&rft.date=2023-06-08&rft.volume=25&rft.issue=1&rft.spage=1&rft.epage=21&rft.pages=1-21&rft.issn=1523-9829&rft.eissn=1545-4274&rft_id=info:doi/10.1146/annurev-bioeng-081622-031203&rft_dat=%3Cproquest_pubme%3E2824687324%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2824687324&rft_id=info:pmid/37289555&rfr_iscdi=true |